## Why option 1 is right Hepatocyte ballooning degeneration (marked **B**) is the cardinal histological feature that distinguishes NASH from simple steatosis (NAFL). While NAFL is characterized by steatosis alone, NASH is defined by the presence of steatosis PLUS hepatocyte ballooning (along with lobular inflammation and/or Mallory-Denk bodies). Ballooning represents active hepatocellular injury with cytoplasmic clearing and loss of normal architecture, indicating progression beyond simple lipid accumulation. This distinction is critical because NASH carries risk of fibrosis, cirrhosis, and HCC, whereas NAFL has minimal fibrosis risk. The NAS (NAFLD Activity Score) specifically incorporates ballooning as a key component (0-2 points) in staging disease severity (Robbins 10e Ch 18; Harrison 21e Ch 401). ## Why each distractor is wrong - **Option 2**: Ballooning is NOT seen in NAFL by definition. NAFL consists of steatosis alone without inflammation or ballooning. Ballooning is the distinguishing feature that moves a patient from NAFL to NASH, making it highly specific for the latter. - **Option 3**: While Mallory-Denk bodies (marked **C**) are seen in alcoholic hepatitis, hepatocyte ballooning itself is not pathognomonic for alcohol. Ballooning is a hallmark of NASH in non-drinkers and is driven by metabolic dysfunction, oxidative stress, and lipotoxicity rather than ethanol metabolism. - **Option 4**: Ballooning alone does not mandate cirrhosis or transplantation. NASH with ballooning may have no fibrosis (F0), mild fibrosis (F1-F2), or advanced fibrosis (F3-F4). Fibrosis stage is assessed separately and determines prognosis and transplant candidacy, not ballooning alone. **High-Yield:** Hepatocyte ballooning = NASH; steatosis alone = NAFL. Ballooning is the histological gatekeeper between simple steatosis and progressive steatohepatitis. [cite: Robbins 10e Ch 18; Harrison 21e Ch 401]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.